These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9074522)

  • 21. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
    Baugnet-Mahieu L; Lemaire M; Léonard ED; Léonard A; Gerber GB
    Radiat Res; 1994 Dec; 140(3):429-31. PubMed ID: 7972697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could the treatment of differentiated thyroid carcinoma with 3.7 and 5.55 GBq of (131I)NaI, on an outpatient basis, be safe?
    de Carvalho JW; Sapienza M; Ono C; Watanabe T; Guimarães MI; Gutterres R; Marechal MH; Buchpiguel C
    Nucl Med Commun; 2009 Jul; 30(7):533-41. PubMed ID: 19436231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 25. 131I ablation treatment in young females after the Chernobyl accident.
    Travis CC; Stabin MG
    J Nucl Med; 2006 Oct; 47(10):1723-7. PubMed ID: 17015910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
    Puerto S; Marcos R; Ramírez MJ; Galofré P; Creus A; Surrallés J
    Mutat Res; 2000 Aug; 469(1):147-58. PubMed ID: 10946251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dosimetric measurements and early complications in patients with differentiated thyroid carcinomas treated with radioactive iodine].
    Malesević M; Stefanović L; Adzić O; Mihoci Z; Elez D
    Med Pregl; 1992; 45(11-12):427-31. PubMed ID: 1344442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy).
    Bianchi L; Baroli A; Lomuscio G; Pedrazzini L; Pepe A; Pozzi L; Chiesa C
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):515-21. PubMed ID: 23358404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of dialysis on 131I kinetics and dosimetry in thyroid cancer patients--a pharmacokinetic model.
    Pahlka RB; Sonnad JR
    Health Phys; 2006 Sep; 91(3):227-37. PubMed ID: 16891898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
    Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
    J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
    Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D; M'Kacher R; Adjadj E; Dossou J; de Vathaire F; Parmentier C
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):174-9. PubMed ID: 15449047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer.
    Freudenberg LS; Jentzen W; Marlowe RJ; Koska WW; Luster M; Bockisch A
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):690-3. PubMed ID: 18058605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer.
    Khvostunov IK; Saenko VA; Krylov V; Rodichev A; Yamashita S
    Radiat Environ Biophys; 2017 Aug; 56(3):213-226. PubMed ID: 28526978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micronuclei and 3AB-index in patients receiving iodine-131 therapy.
    Catena C; Villani P; Nastasi R; Conti D; Righi E; Salerno G; Righi VA; Ronga G
    J Nucl Biol Med (1991); 1994 Dec; 38(4):586-93. PubMed ID: 7786922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic effects of radioiodine therapy: a 20-year follow-up study.
    Livingston GK; Khvostunov IK; Gregoire E; Barquinero JF; Shi L; Tashiro S
    Radiat Environ Biophys; 2016 May; 55(2):203-13. PubMed ID: 27015828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetic study of radiation burden in thyroid disease patients treated with external irradiation or radioiodine.
    Gundy S; Katz N; Füzy M; Esik O
    Mutat Res; 1996 Jun; 360(2):107-13. PubMed ID: 8649463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic Damage Induced by Radioiodine Therapy: A Follow-Up Case Study.
    Khvostunov IK; Nasonova E; Krylov V; Rodichev A; Kochetova T; Shepel N; Korovchuk O; Kutsalo P; Shegai P; Kaprin A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.